Diabetic nephropathy

被引:0
|
作者
Menne, J. [1 ]
Haller, H. [1 ]
机构
[1] Hannover Med Sch, D-30625 Hannover, Germany
来源
INTERNIST | 2011年 / 52卷 / 05期
关键词
Albuminuria; Hypertension; HbA(1c); Renin angiotensin system; Diabetic nephropathy; STRUCTURAL-FUNCTIONAL RELATIONSHIPS; CARDIOVASCULAR EVENTS; RENAL-DISEASE; MICROALBUMINURIA; INTERVENTION; METAANALYSIS; ALBUMINURIA; PROTEINURIA; PREVENTION; MORTALITY;
D O I
10.1007/s00108-010-2761-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is the most common cause of end-stage renal disease. Since the disease progresses very slowly and usually takes more than 20 years before terminal renal failure occurs, early intervention is of great importance in order to prevent this disabling complication. A good control of diabetes with HbA(1c) levels around 7% is desirable. At least as important is the treatment of elevated blood pressure values. The target value for patients with diabetes has been adjusted in the last year and is now 130-139/80-85 mmHg. Should (micro-)albuminuria or renal insufficiency be present the blood pressure target is < 130/80 mmHg. For the control of hypertension the use of ACE inhibitors or angiotensin receptor blockers is recommended. In addition, the control of other risk factors and appropriate therapeutic intervention is required. A multifactorial intervention leads to the best results and can avoid the occurrence or progression of diabetic kidney disease and other micro- and/or macrovascular complications.
引用
收藏
页码:495 / +
页数:8
相关论文
共 50 条
  • [11] The Endothelium in Diabetic Nephropathy
    Advani, Andrew
    Gilbert, Richard E.
    SEMINARS IN NEPHROLOGY, 2012, 32 (02) : 199 - 207
  • [12] The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy
    Hirst, Jennifer A.
    Taylor, Kathryn S.
    Stevens, Richard J.
    Blacklock, Claire L.
    Roberts, Nia W.
    Pugh, Christopher W.
    Farmer, Andrew J.
    KIDNEY INTERNATIONAL, 2012, 81 (07) : 674 - 683
  • [13] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Masakazu Haneda
    Kazunori Utsunomiya
    Daisuke Koya
    Tetsuya Babazono
    Tatsumi Moriya
    Hirofumi Makino
    Kenjiro Kimura
    Yoshiki Suzuki
    Takashi Wada
    Susumu Ogawa
    Masaaki Inaba
    Yoshihiko Kanno
    Takashi Shigematsu
    Ikuto Masakane
    Ken Tsuchiya
    Keiko Honda
    Kazuko Ichikawa
    Kenichiro Shide
    Clinical and Experimental Nephrology, 2015, 19 : 1 - 5
  • [14] Potential serum biomarkers for early detection of diabetic nephropathy
    Motawi, Tarek Kamal
    Shehata, Nagwa Ibrahim
    ElNokeety, Mahmoud Mohamed
    El-Emady, Yasmin Farid
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 136 : 150 - 158
  • [15] Effects of mineralocorticoid receptor antagonists on the progression of diabetic nephropathy
    Sun, Li-Jing
    Sun, Yan-Ni
    Shan, Jian-Ping
    Jiang, Geng-Ru
    JOURNAL OF DIABETES INVESTIGATION, 2017, 8 (04) : 609 - 618
  • [16] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Haneda M.
    Utsunomiya K.
    Koya D.
    Babazono T.
    Moriya T.
    Makino H.
    Kimura K.
    Suzuki Y.
    Wada T.
    Ogawa S.
    Inaba M.
    Kanno Y.
    Shigematsu T.
    Masakane I.
    Tsuchiya K.
    Honda K.
    Ichikawa K.
    Shide K.
    Diabetology International, 2014, 5 (4) : 207 - 211
  • [17] A new classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
    Haneda, Masakazu
    Utsunomiya, Kazunori
    Koya, Daisuke
    Babazono, Tetsuya
    Moriya, Tatsumi
    Makino, Hirofumi
    Kimura, Kenjiro
    Suzuki, Yoshiki
    Wada, Takashi
    Ogawa, Susumu
    Inaba, Masaaki
    Kanno, Yoshihiko
    Shigematsu, Takashi
    Masakane, Ikuto
    Tsuchiya, Ken
    Honda, Keiko
    Ichikawa, Kazuko
    Shide, Kenichiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 1 - 5
  • [18] COULD PROTEINURIA PREDICT THE RENAL PROGNOSES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND DIABETIC NEPHROPATHY?
    Wang, J. L.
    Sun, Y.
    Wang, Y.
    Wu, Y.
    Liu, F.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2022, 18 (01) : 29 - 34
  • [19] Peripheral dopamine suppression and elevated cystatin C in early diabetic nephropathy in spontaneously diabetic rats
    Horita, Shoichiro
    Watanabe, Guy
    Misaka, Shingen
    Taira, Shu
    Satoh, Mamoru
    Maejima, Yuko
    Shimomura, Kenju
    Shimabukuro, Michio
    Kazama, Junichiro James
    Shigetomi, Shuichi
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 327 (04) : F581 - F590
  • [20] Vitamin B receptor and its protective role in diabetic nephropathy
    Guan Xiaoling
    Yang Huajie
    Zhang Wei
    Wang Huanjun
    Liao Lin
    CHINESE MEDICAL JOURNAL, 2014, 127 (02) : 365 - 369